Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.5000
+0.0050 (1.01%)
Sep 18, 2026, 1:20 PM AEST
Cambium Bio Revenue
In the fiscal year ending June 30, 2026, Cambium Bio had annual revenue of 1.23M AUD with 58.17% growth. Cambium Bio had revenue of 681.55K in the half year ending June 30, 2026, with 285.07% growth.
Revenue
1.23M
Revenue Growth
+58.17%
P/S Ratio
11.89
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.57M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 1.23M | 450.76K | 58.17% |
| Jun 30, 2025 | 774.88K | 597.89K | 337.80% |
| Jun 30, 2024 | 177.00K | -837.20K | -82.55% |
| Jun 30, 2023 | 1.01M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.